|
Mycoplasma Hominis Real Time PCR Kit
Laboratories evaluating the Mycoplasma Hominis Real Time PCR Kit must separate commercial availability from intended use. The listed RUO status and performance specifications shape how the kit can be adopted.
Molecular testing workflows depend on extraction, amplification, detection, and documentation. The kit specifies 20 μL sample input and a 94-minute testing time, giving lab managers concrete parameters for run scheduling and plate setup.
Sample types named are male urethral swabs, female cervical or vaginal swabs, and urine. Storage is -20±5℃ with a 12-month shelf life. The stated limit of detection is 471 copies/mL.
Bioperfectus supplies the kit in 24T and 48T configurations under catalog codes JB(Z)60109NW-24T and JB(Z)60109NW-48T. The product page identifies regulatory status as RUO, so use is directed to research settings rather than a confirmed clinical diagnostic claim.
Procurement should confirm whether the laboratory’s extraction platform, thermocycler, and reporting workflow are compatible with the kit’s instructions for use. Package size affects ordering cadence, freezer space, and waste from unused reactions.
Buyers should verify local regulatory requirements, training, and documentation before purchase. Scientific China lists sourcing, configuration, MOQ, and logistics support, but laboratory qualification remains with the buyer.
RUO labeling is not a minor detail; it determines where the kit can be deployed and how results can be described.
Why it matters:
For operators, the decisive checks are regulatory status, sample-type fit, storage, and run time—not catalog breadth. Those factors determine whether the kit can be validated and supported in a specific laboratory.
View Product →
|
ScientificChina — tracking China’s science, technology, and industrial systems through the lens of real-world products.
Follow ScientificChina for deeper insight into the infrastructure behind global innovation.
Visit ScientificChina.
ScientificChina is an independent commercial platform and is not affiliated with or endorsed by any Chinese government agency or public institution.
|
|